These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33863794)

  • 1. Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study.
    Holbrook A; Benipal H; Paterson JM; Martins D; Greaves S; Lee M; Gomes T
    CMAJ Open; 2021; 9(2):E364-E375. PubMed ID: 33863794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.
    Lip GYH; Murphy RR; Sahiar F; Ingall TJ; Dhamane AD; Ferri M; Hlavacek P; Preib MT; Keshishian A; Russ C; Rosenblatt L; Yuce H; Deitelzweig S
    JAMA Netw Open; 2022 Aug; 5(8):e2229333. PubMed ID: 36044214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation.
    Nielsen PB; Larsen TB; Skjøth F; Lip GY
    JAMA Intern Med; 2017 Apr; 177(4):563-570. PubMed ID: 28241151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nonvalvular atrial fibrillation: data from the Observatory of Cardiovascular Diseases in the province of Trieste (Italy)].
    Mazzone C; Carriere C; Grande E; Iorio AM; Barbati G; Zecchin M; Serdoz LV; Cioffi G; Tarantini L; Sinagra G; Scardi S; Di Lenarda A
    G Ital Cardiol (Rome); 2015 Jun; 16(6):361-72. PubMed ID: 26156697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NAÏVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study.
    Gennaro N; Ferroni E; Zorzi M; Denas G; Pengo V
    Int J Cardiol; 2024 Jan; 394():131369. PubMed ID: 37722453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboembolism and bleeding in patients with atrial fibrillation and liver disease - A nationwide register-based cohort study: Thromboembolism and bleeding in liver disease.
    Steensig K; Pareek M; Krarup AL; Sogaard P; Maeng M; Tayal B; Lee CJ; Torp-Pedersen C; Lip GY; Holland-Fischer P; Kragholm KH
    Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):101952. PubMed ID: 35609823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation and validation of predictors of oral anticoagulant-related adverse events in seniors transitioning from hospital to home.
    Benipal H; Holbrook A; Paterson JM; Douketis J; Foster G; Ma J; Thabane L
    Thromb Res; 2021 Oct; 206():18-28. PubMed ID: 34391064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of hemorrhage during warfarin therapy for atrial fibrillation.
    Gomes T; Mamdani MM; Holbrook AM; Paterson JM; Hellings C; Juurlink DN
    CMAJ; 2013 Feb; 185(2):E121-7. PubMed ID: 23184840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
    Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing of oral anticoagulants in the emergency department and subsequent long-term use by older adults with atrial fibrillation.
    Atzema CL; Jackevicius CA; Chong A; Dorian P; Ivers NM; Parkash R; Austin PC
    CMAJ; 2019 Dec; 191(49):E1345-E1354. PubMed ID: 31818927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Oral Anticoagulation Therapy over One Year in 51,000 Atrial Fibrillation Patients at Risk for Stroke: A Practice-Derived Study.
    Hohnloser SH; Basic E; Nabauer M
    Thromb Haemost; 2019 Jun; 119(6):882-893. PubMed ID: 30900220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry.
    Essien UR; Chiswell K; Kaltenbach LA; Wang TY; Fonarow GC; Thomas KL; Turakhia MP; Benjamin EJ; Rodriguez F; Fang MC; Magnani JW; Yancy CW; Piccini JP
    JAMA Cardiol; 2022 Dec; 7(12):1207-1217. PubMed ID: 36287545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of oral anticoagulation in US older adults newly diagnosed with atrial fibrillation during hospitalization.
    Troy AL; Herzig SJ; Trivedi S; Anderson TS
    J Am Geriatr Soc; 2023 Sep; 71(9):2748-2758. PubMed ID: 37092856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer.
    O'Neal WT; Claxton JS; Sandesara PB; MacLehose RF; Chen LY; Bengtson LGS; Chamberlain AM; Norby FL; Lutsey PL; Alonso A
    J Am Coll Cardiol; 2018 Oct; 72(16):1913-1922. PubMed ID: 30309468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selecting the right anticoagulant for stroke prevention in atrial fibrillation.
    Kundnani NR; Rosca CI; Sharma A; Tudor A; Rosca MS; Nisulescu DD; Branea HS; Mocanu V; Crisan DC; Buzas DR; Morariu S; Lighezan DF
    Eur Rev Med Pharmacol Sci; 2021 Jul; 25(13):4499-4505. PubMed ID: 34286492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboembolic and bleeding complications during oral anticoagulation therapy in cancer patients with atrial fibrillation: a Danish nationwide population-based cohort study.
    Ording AG; Horváth-Puhó E; Adelborg K; Pedersen L; Prandoni P; Sørensen HT
    Cancer Med; 2017 Jun; 6(6):1165-1172. PubMed ID: 28544489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Resumption of anticoagulant therapy after major bleeding and recurrence of hemorrhagic complications in patients with atrial fibrillation with a high risk of stroke and thromboembolism (based on the results of 20 years of observation)].
    Mironova Staroverova AI; Panchenko EP; Kropacheva ES; Zemlyanskaya OA
    Ter Arkh; 2020 Oct; 92(9):15-23. PubMed ID: 33346426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of potentially avoidable anticoagulant-associated hemorrhagic and thromboembolic events in the elderly.
    van Walraven C; Oake N; Wells PS; Forster AJ
    Chest; 2007 May; 131(5):1508-15. PubMed ID: 17317732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time Trends in Patient Characteristics, Anticoagulation Treatment, and Prognosis of Incident Nonvalvular Atrial Fibrillation in the Netherlands.
    Chen Q; Toorop MMA; Tops LF; Lijfering WM; Cannegieter SC
    JAMA Netw Open; 2023 Apr; 6(4):e239973. PubMed ID: 37097630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.